Vimarsana
Biggest News Aggregation in the World

Page 3 - Dane Andreeff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dane Andreeff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dane Andreeff Today - Breaking & Trending Today

Helius Medical Technologies to Present at NobleCon19 Annual Conference - Vimarsana News

Helius Medical Technologies to Present at NobleCon19 Annual Conference

NEWTOWN, Pa., Nov. 30, 2023 -- Helius Medical Technologies, Inc. , a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today...

Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q3 2023 Earnings Call Transcript - Vimarsana News

Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q3 2023 Earnings Call Transcript

Operator: Good day, everyone. My name is Chelsea, and I will be your conference operator.

Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results - Vimarsana News

Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results

-- Cash runway extended into Q2 2024 --

Helius Medical Technologies, Inc. (NASDAQ:HSDT) Sees Significant Decline in Short Interest - Vimarsana News

Helius Medical Technologies, Inc. (NASDAQ:HSDT) Sees Significant Decline in Short Interest

Helius Medical Technologies, Inc. (NASDAQ:HSDT – Get Free Report) was the recipient of a significant decrease in short interest during the month of September. As of September 30th, there was short interest totalling 79,400 shares, a decrease of 57.4% from the September 15th total of 186,400 shares. Approximately 14.9% of the shares of the company […]

Helius Medical Technologies, Inc. Receives Letter of Intent - Vimarsana News

Helius Medical Technologies, Inc. Receives Letter of Intent

-- PoNS® devices to be provided to a least five sites in five separate administrative regions within Québec ---- Government-funded initiative will evaluate...